Information  X 
Enter a valid email address

Judges ScientificPLC (JDG)

  Print      Mail a friend       Annual reports

Friday 06 December, 2019

Judges ScientificPLC

Director/PDMR Shareholding

RNS Number : 0966W
Judges Scientific PLC
06 December 2019
 

Judges Scientific plc

(the "Company")

Director/PDMR Shareholding

 

In accordance with notification obligations under article 19.3 of the Market Abuse Regulation, the Company announces that on 5 December 2019 David Cicurel, CEO, transferred the beneficial interest in 24,000 ordinary shares of 5 pence each in the Company ("Ordinary Shares") to the Shoftim Charitable Trust (the "Charity").

David Cicurel and Ralph Cohen, Non-Executive Director of Judges, are trustees of the Charity. Following this gift David Cicurel is benefically interested in 715,408 Ordinary Shares.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

David Cicurel

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Judges Scientific plc

b)

 

LEI

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Gift beneficial interest in 24,000 Ordinary Shares to the Charity.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

0p

 

24,000

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A (single transaction)

e)

 

Date of the transaction

 

 

05/12/2019

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

 

Stephane Auton

Edward Mansfield

Sarah Mather

Tel: +44 (0) 20 7408 4090

 

Liberum (Joint Broker)

 

Bidhi Bhoma

Euan Brown

 

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Tel:  +44 (0) 20 3100 2222

Rebecca Sanders-Hewett

Sam Modlin

Tel: +44 (0) 20 3865 4219

[email protected]

 

 

Notes to editors: 

 

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses.  The Group currently consists of 17 businesses acquired since it was re-admitted to AIM in 2005.   

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queens' awards for innovation and export. 

 

Judges Scientific maintains a policy to selectively acquire businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, payment of increasing dividends and through organic growth which the Group encourages by creating an environment for businesses to thrive in, with support and advice for entity management teams.  

 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins. 

 

For further information, please visit www.judges.uk.com 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHBSBDDCUGBGCL

a d v e r t i s e m e n t